As the search for a cure for COVID-19 continues, researchers have a new tool to help: an organism’s genome.
The Human Genome Sequencing Consortium, which was formed by a consortium of researchers led by Columbia University and Johns Hopkins University, will be the world’s largest single human genome sequencing project.
It will collect all the genetic information of people living in the United States and around the world for the next 10 years.
The consortium will create a platform that will allow scientists to study genetic changes that may be related to disease, but it also has the ability to help researchers better understand how the human body interacts with the environment, like climate change.
“The goal of the project is to provide the first glimpse of what happens to the human microbiome when we live in a world where the average person is surrounded by a multitude of different environments, many of which are changing at a faster pace than ever before,” said John Stempel, a senior fellow at Columbia’s Mailman School of Public Health.
“That’s what our collaboration will allow us to learn.”
Stempel said he was excited to work with the consortium to create a new approach to studying human microbiome interactions.
He said he thinks this approach could provide insight into the human gut microbiome, which he said has been “under-explored” in other labs.
This is the first time a human genome has been sequenced in-house, and its contents will be shared with the wider scientific community.
The project’s first publication, published last month, included genome-wide data from 1,000 people from around the globe.
The data were compared with the genomes of individuals in the consortium, which includes scientists at universities in the U.S. and other countries, and researchers at the University of California, Berkeley, in California.
The consortium is using the latest sequencing technology to study the human genomes of people in more detail than ever.
The consortium will release more information about the project on May 1, 2019.
“It is amazing to see a project that has the potential to be the most comprehensive human microbiome project ever,” said Christopher Bailenson, a professor at the UC Berkeley Department of Medicine who is involved in the project.
“What’s interesting is that it’s a collaborative effort with scientists from across the globe.”
Bailenson said that the consortium’s genome sequencing data will provide information on how human populations are changing in a global context.
“We’ve had a lot of questions, and we wanted to get a little bit more granular in understanding what is going on in a particular community,” Bailensen said.
“This is really a big leap forward.
And I think it will give us a much more complete picture of what’s going on.”
The consortium says its data will also help scientists better understand the human immune system, which has been under-studied.
Bailinson said it will allow researchers to look at the immune system in a new way.
“This is a really exciting time for studying immune systems, because we know how the immune cells function, and it’s been really challenging to understand how they interact,” he said.
Bailinson and his team are working to understand the way that a variety of bacterial strains may interact with each other and with human cells.
For example, some strains of bacteria may attack and kill human cells, while others may not, Bailisson said.
The project has raised $1.8 billion for the project and has plans to continue developing technology.
The first human genome project in history, the consortium is led by the University and includes scientists from Johns Hopkins, the Johns Hopkins Hospital, the University College London, the Broad Institute, the Harvard Medical School, the Max Planck Institute for Evolutionary Anthropology, the Institute of Bioinformatics and Genetics, the New York University Medical Center, the National Institutes of Health, the Rockefeller University, the Scripps Research Institute, and the National Science Foundation.
The team plans to release its first publication on May 15, 2019, and will publish a follow-up paper in the journal Science in May 2020.